NCT06640153View on ClinicalTrials.gov

MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 21, 2024

Primary Completion Date

August 24, 2025

Study Completion Date

August 24, 2027

Conditions
Gastric Cancer, Gastroesophageal Junction Cancer
Interventions
DIAGNOSTIC_TEST

mpMRI

Gastroesophageal junction or upper gastric adenocarcinoma patients undergo mpMRI at siewert classification, length of esophageal involvement, primary staging and restaging

Trial Locations (1)

Unknown

The First Affiliated Hospital with Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT06640153 - MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma | Biotech Hunter | Biotech Hunter